Michelle Hernandez
University of North Carolina, Chapel Hill · Associate Professor of Pediatrics · University of North Carolina
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
21
all conditions, ClinicalTrials.gov
NIH grants tied to them
4
2 more share only the name and are not shown
Trial papers
225
PubMed author-name match
Trials
Studies that name Michelle Hernandez as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:47 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07600190 · Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)University of North Carolina, Chapel Hill · not yet recruiting · Asthma (Diagnosis), Persistent Asthma, Moderate Asthma Exacerbation · principal investigator
- Ph1/Ph2NCT04035109 · Anakinra as a Rescue Treatment for Allergic InflammationUniversity of North Carolina, Chapel Hill · withdrawn · Asthma, Allergic · principal investigator
- Early Ph1NCT03780387 · Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen InhalationUniversity of North Carolina, Chapel Hill · terminated · Asthma Atopic · principal investigator
- Ph1NCT03623022 · Effects of 20,000 EU of Clinical Center Reference Endotoxin (CCRE) Versus Placebo(ENDOHEART)University of North Carolina, Chapel Hill · completed · Healthy · principal investigator
- Ph1/Ph2NCT03513471 · Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway InflammationUniversity of North Carolina, Chapel Hill · withdrawn · Asthma · principal investigator
- Ph1/Ph2NCT03513458 · Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway InflammationUniversity of North Carolina, Chapel Hill · withdrawn · Asthma · principal investigator
- Ph1NCT03508479 · Study of Airway Inflammatory Responses to Experimental Rhinovirus InfectionUniversity of North Carolina, Chapel Hill · withdrawn · Healthy Volunteers, Rhinovirus · principal investigator
- Early Ph1NCT03049111 · Screening Inhaled Allergen Challenge for Dermatophagoides FarinaeUniversity of North Carolina, Chapel Hill · terminated · Asthma · principal investigator
- Ph1NCT03031145 · Investigation of the Impact of Smoking Status on Allergen-induced Nasal Airway Inflammation Using a Cat Hair (Felis Domesticus) Extract Nasal Allergen Challenge ModelUniversity of North Carolina, Chapel Hill · withdrawn · Tobacco Smoking, Healthy Participants, E-cigarette Smokers · principal investigator
- Ph1NCT03023397 · Evaluation of the Effect of a Nasal Allergen Challenge With Dermatophagoides Farinae Extract on Nasal Airway Inflammation in Allergic Individuals, Comparing E-cigarette Users to Cigarette Smokers and Non-smokers.University of North Carolina, Chapel Hill · terminated · Healthy Participants, Tobacco Smokers · principal investigator
- Ph1NCT02847247 · Systemic Inflammatory Response to CCREUniversity of North Carolina, Chapel Hill · completed · Healthy · principal investigator
- N/ANCT02671643 · To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent AsthmaUniversity of North Carolina, Chapel Hill · completed · Asthma · principal investigator
- N/ANCT02662413 · To Determine the Validity of the ACT in an Adolescent Population With Persistent AsthmaUniversity of North Carolina, Chapel Hill · completed · Asthma · study director
- N/ANCT01891630 · Observational Assessment of Baseline Asthma Control in African-American ChildrenUniversity of North Carolina, Chapel Hill · completed · Asthma · principal investigator
- N/ANCT01625130 · Effect of Sulforaphane-rich Broccoli Sprout Homogenate on Ozone Induced Inflammation Through Modulation of NRF2University of North Carolina, Chapel Hill · completed · Healthy · principal investigator
- N/ANCT01489514 · Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic SubjectsUniversity of North Carolina, Chapel Hill · completed · Peanut Allergy · principal investigator
- Ph1NCT01369017 · Effect of Interleukin-1 Receptor Antagonist on Inhalation of 20,000 EU Clinical Ctr Reference Endotoxin in Normal VolunteersMichelle Hernandez, MD · completed · Healthy Control Subjects · principal investigator
- Ph1NCT00927329 · Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite ExtractUniversity of North Carolina, Chapel Hill · withdrawn · Dermatophagoides Farinae Allergy, Asthma, Healthy · study director
- Ph1NCT00836368 · In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic AsthmaticsUniversity of North Carolina, Chapel Hill · completed · Allergic, Asthmatic, Allergy · principal investigator
- Ph1NCT00654134 · Inhalation of 20,000 Endotoxin Units(EU) of Clinical Center Reference Endotoxin in Healthy VolunteersUniversity of North Carolina, Chapel Hill · completed · Healthy Adults · principal investigator
- Ph1NCT00631085 · Effect of Gamma Tocopherol Supplementation on Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal AdultsUniversity of North Carolina, Chapel Hill · completed · Healthy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- CTSA K12 Program at UNCK12TR004416 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2023 to 2026 · $1,619,730 awarded in 2026Same name and institution; not confirmed by an ID
- Rescue anakinra treatment for moderate asthma attacksR34HL179910 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2025 to 2026 · $233,250 awarded in 2026Grant number is on one of their registry trials
- IL-1 receptor blockade as a novel treatment for exacerbation of allergic airway responses in humansR01HL135235 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2017 to 2021 · $301,726 awarded in 2021Grant number is on one of their registry trials
- Down-regulation of oxidant-induced airway inflammation though modulation of NRF2K23ES021745 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2012 to 2014 · $203,898 awarded in 2014Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd P50HL120100 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Robert Tarran · fiscal years 2013 to 2017Named on NCT03023397
- Immunobiology of Acute Environmental AsthmaU19AI077437 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David B. Peden · fiscal years 2008 to 2013Named on NCT01369017
- Biomarkers & Sample Repository CoreP01AT002620 · NCCIH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI D. Patel Dhavalkumar · fiscal years 2004 to 2008Named on NCT00836368, NCT00631085
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:47 UTC. The ranking covers the 200 most relevant of 225 PubMed records, and a shared surname and initials can bring in a namesake. All 225 on PubMed
- 1,090 citationsRCR 44.6
- 936 citationsRCR 31.8
- Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.N Engl J Med · 2013452 citationsRCR 11.9
- 392 citationsRCR 11.2
- 294 citationsRCR 6.7
- 246 citationsRCR 6.8
- 221 citationsRCR 5.0
- Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.Eur Heart J · 2003213 citationsRCR 4.3
- Individualised perioperative open-lung approach versus standard protective ventilation in abdominal surgery (iPROVE): a randomised controlled trial.Lancet Respir Med · 2018207 citationsRCR 11.9
- Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial.Crit Care Med · 2016200 citationsRCR 8.7